M2D2 has announced that Jennifer Griffin, Ph.D., Vice President, Industry Strategy and Investments at Massachusetts Life Sciences Center (MLSC), will deliver keynote remarks at the 9th Annual M2D2 $200K Challenge Finalist Pitch-Off. In response to the COVID-19 pandemic, this year’s Pitch-Off will take place virtually on Thursday, September 17 beginning at 5:00 pm eastern time. Life sciences entrepreneurs, investors, academics, researchers, students, and media from anywhere are invited. Tickets are free with registration.Continue reading
The $200K Challenge brings together many of the brightest life sciences startups to pitch their innovations for a chance to win $200K of in-kind services. One of this year’s 15 finalists is Oriel Research Therapeutics, whose goal is to identify sepsis at its early stage, before it becomes very challenging to treat and in many cases irreversible.
We talked with Eila Arich-Landkof, founder of Oriel Research Therapeutics, to learn more about her personal inspiration that led them to the $200K Challenge.Continue reading
In just one month, 15 innovative life sciences startups will pitch their unique solutions $200K Challenge 2020 Finalist Pitch-Off. We were able to meet another finalist, ExonanoRNA. CEO Fengmei Pi told us what led them and their innovation to the $200K Challenge.Continue reading
M2D2 Resident Company MedicaMetrix has been making great strides in its endeavors over the past few months. We are excited to share some of their major recent successes, including new financing deals, acquisition of essential products and tools, and approval for two large clinical trials this coming fall.Continue reading
After postponing its 9th Annual M2D2 $200K Challenge five months ago in response to the coronavirus outbreak, M2D2 has announced that the show will go on in September and October—this time, virtually.Continue reading
In light of recent unprecedented events surrounding the COVID-19 outbreak, the decision has been made to host the 2020 $200K Challenge virtually this fall with free registration. The PitchOff is scheduled for Thursday, September 17th from 5:00- 8:00 pm, and the Award Celebration is set for Thursday, October 1st at 5:00 pm.
As the newly rescheduled virtual events approach, we want to shine the spotlight on another unique $200K Challenge finalist. MicroBioMed is developing an operator-independent measurement device to quantitatively study vaginal wall skin properties. We talked to William Gardetto, COO of MicroBioMed to learn more about what led them to the $200K Challenge.Continue reading
Our finalists for this year’s $200K Challenge are experiencing our traditional event in a very unique way. The event will be held virtually, with the PitchOff taking place on September 17th and the Award Celebration on October 1st, and will be completely free with registration. While this year’s event looks different, we still want to bring attention to each of our unique finalists and their innovations.Continue reading
The summer of 2020 continues to bring forth exciting news on our resident companies. LaunchPad Medical has announced that it received approval from the Medicines and Healthcare products Regulatory Agency in the United Kingdom to start a 15-patient pilot clinical study. The goal is to examine the safety and efficacy of Tetranite®, the company’s bone adhesive biomaterial, to immediately stabilize dental implants following tooth extractions.Continue reading
Though this year’s $200K Challenge will take place virtually, this year’s finalists’ are still top of mind. The PitchOff will now be held on Zoom on September 17th from 5-8pm, as will the Award Celebration on October 1st at 5pm. Additionally, the $200K Challenge will be free with registration.
Recently, we caught up with Michael House, President of Cx Therapeutics. His titles include Principal Investigator, Mother Infant Research Institute and Associate Professor of Medicine at Tufts Medical Center.Continue reading
In April of 2019, Newburyport, Massachusetts-based EnClear Therapies was named a winner in the 8th annual M2D2 $200K Challenge. Their innovation: a treatment device to stop progress of neurodegenerative diseases. The 2020 Challenge is coming up this fall, and because we’re always interested in the progress of past winners, we reached out to EnClear’s Vice President of R&D/Operations Kevin Kalish to get an update.Continue reading